Elevated expression of TRIM33 is significantly associated with worse survival for Uterine Corpus Endometrial Carcinoma (UCEC) patients and with better survival for COAD and KIRC patients (Figure 1C). Here, TRIM33 is linked to colon adenocarcinoma.